Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season

Completed · Phase 4 · Has a placebo group

Conditions studied: Influenza, Healthy

In brief

This prospective annual release study is designed to evaluate the safety of 1 new influenza virus vaccine strain to be included in FluMist Quadrivalent for the 2017-2018 influenza season.

Key facts

Study ID

NCT03158038

Run by

MedImmune LLC

People needed

300

Starts

2017-05-30

Expected to finish

2017-12-14

Last updated by the study team

2019-01-04

Who can join

Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.

Where it is running

• Research Site — Stockbridge, Georgia, United States
• Research Site — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.